Variable | Group R (n = 22) | Group BR (n = 22) | p value |
---|
Age (years) | 65 (58,69) | 65 (60,70) | 0.25 |
Sex male/female | 15/7 | 7/15 | 0.034* |
ASA status 1/2 | 10/12 | 12/10 | 0.76 |
BMI | 25 (23,27) | 23 (19,25) | 0.06 |
Right/Left | 8/14 | 8/14 | 1.00 |
Anchors | 3 (3,4) | 3 (1.75,4) | 0.25 |
Surgical time (min) | 108 (90,133) | 95 (74,115) | 0.11 |
Fentanyl (mcg) | 100 (100,163) | 100 (100,150) | 0.77 |
- There was no difference in the demographic data, except for the sex ratio
- All measured values are presented as median (interquartile range) or numbers of patients. Group R: 0.375 % ropivacaine (20 mL), group BR: betamethasone 4 mg (1 mL) + 0.375 % ropivacaine (19 mL), ASA: American Society of Anesthesiologist, BMI: Body mass index, Anchors: number of implanted anchors. *P < 0.05. (See: Additional file 1)